Swansea-Led Project 'Could Transform Clot Treatment'
Researchers are developing a cutting-edge blood test that measures clot formation and breakdown from a single sample, which has the potential to improve patient treatment and reduce pressure on the NHS.
Led by Professor Karl Hawkins, alongside colleagues from Swansea University and NHS clinicians, the £1.2 million project is being funded by the UKRI Engineering and Physical Sciences Research Council (EPSRC).
Using rheology—the study of how materials flow and deform—the team is investigating how blood clots respond to stress, an innovative approach that led to the discovery of a key biomarker, paving the way for a next-generation blood test.
The test measures the changes in rheology during the clotting process to accurately track a clot's lifespan—from formation to breakdown—at a level of insight that current methods cannot achieve.
Professor Hawkins, Swansea University Medical School, said:
'By developing advanced rheometric techniques to analyse blood clot behaviour, we can now help create and assess new treatments in a way no other test can, opening the door to better treatment strategies.'
By applying microfluidic technology, researchers can track clot breakdown in real time across vessels of different sizes, offering critical insights for safer, more effective treatments.
Dr Francesco Del Giudice, Associate Professor in the Department of Chemical Engineering and Head of the Rheological Microfluidic Laboratory, part of the Complex Fluids Research Group at Swansea University, said:
'Microfluidics provide unparalleled insights into clot breakdown processes, offering a comprehensive analysis with real-world clinical applications.'
Dr Daniel Curtis, Associate Professor in the Department of Chemical Engineering and Lead of the Advanced Rheometry Laboratory, part of the Complex Fluids Research Group at Swansea University, added:
'This project is a really exciting opportunity to develop new rheometric techniques that will not only support healthcare research but also change the way we study other materials that evolve over time.
'It's also fantastic to be collaborating with the team at the Massachusetts Institute of Technology (MIT) once again, who will be working with us to refine techniques for monitoring how blood clots and other time-dependent materials form and break down.'
The project is part of a £80 million UKRI (EPSRC) initiative, aimed at boosting fundamental research and discovery science, paving the way for clinical applications that could directly improve patient care.
Blood clot-related conditions, including strokes, heart attacks, and deep vein thrombosis, are a major cause of death and disability worldwide, with thousands of hospital admissions each year.
Dr Suresh Pillai, Senior Lecturer in Emergency Medicine at Swansea University and Honorary Consultant in Emergency Medicine and Intensive Care Medicine at Morriston Hospital, Swansea Bay University Health Board, said:
'Blood clot-associated diseases are causing an increasingly significant burden on the NHS. Treatments for these conditions are evolving, but some current treatments carry a risk of complications, such as bleeding. Therefore, there is an urgent need to develop accurate tests to assess patient responses to new therapeutic interventions.'
Professor Owen Guy, Head of Swansea University's Department of Chemistry, added:
'This is a fantastic example of how Swansea's multidisciplinary and internationally collaborative research approach is contributing to novel clot-related technology. The project is targeted towards providing future health impact for NHS patients.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Times
an hour ago
- Times
Sunday Times letters: Restoring public confidence in the NHS
Write to letters@ Shaun Lintern ('An extra £29bn a year to spend, but it's public trust that NHS bosses fear squandering', politics, Jun 15) is right to point out that the public is losing patience with the NHS but he omits to mention that there is still widespread support for the principles of tax funding and universal coverage on which the NHS is based. Restoring public confidence must involve progress in improving patients' access to care and in preventing illness. The government's mission concerning the NHS included improving healthy life expectancy for all and reducing the gap in healthy life expectancy between the English regions. The ten-year NHS plan, which is due to be published soon, must set out the measures that will be taken to implement this mission through action on the wider determinants of health and in the NHS Sir Chris HamChief executive of the King's Fund 2010-18; Solihull, W Midlands Further to your report, the National Health Service, which was founded in the year I was born, has become an outdated concept. The arrogance of NHS and political leaders of all persuasions in failing to embrace or even investigate other countries' health services over the years has led to a failure in cancer care, mental health care and palliative care, as well as an inability to cut waiting times for surgery and improve access to A&E and GP services. France, Canada and other nations run their health services so much better than we do, using hybrid models in which everyone enjoys the benefits. The question is whether Wes Streeting and the present NHS honchos can admit past errors in policy and get their act together. There is more at stake than public Derek Pettit (ret'd)Newnham on Severn, Glos I am mystified why politicians keep saying that workers in the NHS need to be 'more productive'. Staff already go above and beyond what they are paid for in terms of the hours worked and the care given, to compensate for an inadequately sized workforce. There is no point in providing more community facilities for medical investigations if there is nobody to staff them. Remember the staffing struggles at the Nightingale hospitals set up during the pandemic? I was born in the same year as the NHS and, having worked in it, was a long-time supporter of the organisation. Now, like many elderly friends, I have a deep dread of having to go to A&E and perhaps waiting days on a trolley for treatment or HoffState registered nurse (ret'd), London E14 Your report on the chancellor's spending plans is yet another insight into the Labour mindset ('Praying for something to turn up', politics, Jun 15). The ten-year plan to 'plough £750 billion into infrastructure' will include the launch of a website featuring details of the government's 'pipeline of the projects' plus a new industrial strategy to include energy subsidies for manufacturing companies. That's all well and good but others might suggest that, while the nation is hugely in debt, the best policy would be one focusing on consolidation. With the economy on its knees, productivity at its lowest ebb and unemployment at 4.6 per cent — not forgetting the colossal sums suggested for the defence review and the sizeable costs of the spending review — Labour's 'pipeline of the projects' seems more like a 'programme of the vanities'.Alastair ConanCoulsdon, Surrey We should not be wasting taxpayers' money on charging points for electric vehicles because government grants are merely leading councils to rush into installing low-powered chargers instead of providing the infrastructure that drivers need ('Supercharge EVs to drive Britain's car industry out of the doldrums', business, Jun 15). It is fortunate that the private EV charging industry has committed £6 billion to installing public charging. A privately funded rollout would be quicker and more efficient. We know which areas need charging and exactly where to put them. We don't need the government to use taxpayers' money: we simply need it to streamline planning rules and grid connections so we can handle it ourselves. A quicker rollout would not only improve public confidence in electric vehicles but would also create jobs, skills and opportunities. At a time when the government is obsessed with 'growth', it is surprising that it hasn't grasped the EV opportunity with both GhafoorChief Executive, Anthony Horowitz's admission that he dislikes being called Grandpa (Jun 15) led my wife and me to realise we're not alone. We decided our four grandchildren should call us 'Crisp' and 'Jelly'. It's easier for the children and fun for and Jenny ChapmanMendlesham Green, Suffolk I had no problem with being called Grandad but, after a discussion with my granddaughter about rap artists, I am now happy to be known as ForwardRedditch, Worcs Bill Jones outlined a fair way to manage illegal migrants arriving on our shores (letter, Jun 15). The welfare state has been stretched far beyond its limits. In building modern Singapore, the political genius Lee Kuan Yew said his priority was to build a 'fair, not welfare, society', while he thought our welfare state was the root of Britain's malaise. Few would ReidWoodford, Lancs Dianne and Charlie Hubbert, who have fostered more than 50 children, are an inspiration (magazine, Jun 15). Their story was heartwarming, uplifting and made me cry, but for all the right BrennanBolton Your report on gig prices struck a chord ('Hot tickets: are we being ripped off?', culture, Jun 15). A friend and I recently tried to book tickets to see Johnny Marr in Southampton. We called at the specified release time — to be told a minute or so later that the show had sold out. Soon after, £40 tickets for the show were being offered for more than £1,000 each on a resale site. In Europe, tickets are cheaper and more easily available to fans rather than being snapped up by bots and touts. If venues really want to keep live music alive, they need to revert to selling direct to fans, including via record stores and ticket Ladd-JonesSwanmore, Hants Finally parental burnout is 'a thing' ('Don't be ashamed if you're sick of your little darlings', news, Jun 15). For years I assumed I was the only mother who dreaded weekends and holidays as I didn't have the patience required to be both nurturing and entertaining for hours on end. Sometimes I'd hope for rain so instead of taking them to the park I could close my eyes on the sofa while they made a den out of chairs and sheets. Striving for perfection helps no one, least of all children, and merely provokes self-loathing. My children are now 26 and 27, with fond memories of being urged to watch yet another Thomas the Tank Engine video so that their father and I could take a CalmanLondon SE21 Dominic Lawson's article 'Putin's sway over the US is worse than you think' (Jun 15) prompted me to look at the way Vladimir Putin took over the Russian Federation. In the early days of his rule he ensured he had all the 'dirt' on his victims before toppling them. Perhaps this is the case with President Trump, whom Putin appears to disdain but who is the right man in the right place to help Putin to save his own ServaesHambledon, Surrey It is no surprise that UK chief executives are falling behind their US counterparts when half of the UK's productivity gap with the US is down to poor management capabilities ('The recipe for a great British CEO', books, Jun 15). As an American who has lived in the UK for three decades, I have seen how seriously the US takes management: investing in business schools, training chief executives in people leadership and strategy and valuing management experience. In the UK we still live with the David Brent effect, treating middle managers as punchlines instead of vital leaders. Unsurprisingly, 82 per cent of managers are given the role with no formal training. We ought not to write off our chief executives but instead train FranckeCEO, Chartered Management Institute Perhaps Professor Elizabeth Whittaker should 'employ' old people like me (I am 89) to tell parents who are scared to inoculate their children how awful childhood diseases can be ('The antivax whisperer winning the wary round to the jab', news, Jun 15). In 1942, aged six, I contracted measles. A sturdy child, I recovered fairly quickly, but my sister, aged three, was desperately ill and lost the sight in one eye. In 1965, our daughters also contracted measles and were both very ill. To our great relief, by the time our third daughter was born the measles vaccine was available. My grandmother had 13 children; six died of childhood illnesses. So much has been achieved since then. We must not let it be thrown away because of HartWatford I loved Matt Rudd's article on artificial fragrances and his weekly shopping woes (magazine, Jun 15). I, too, bought coconut-scented loo rolls by mistake. Looking on the bright side, at least my bathroom smells like a tropical MacLeanCheltenham Send your letter to: letters@ Please include an address for publication and a phone number in case of any queries. Letters should be received by midday on the Thursday before publication.
Times
2 hours ago
- Times
A robot surgeon? I'll put my money on that
T hank you for waiting, the robot will see you now. Nine in ten keyhole operations won't need a human surgeon in the room within the next decade, according to the NHS. One in five operations are already carried out by robots, guided remotely, to improve outcomes while cutting costs. Science fiction is becoming surgical fact because robotic-assisted surgery can mean smaller incisions, reduced scarring and quicker recovery. There's no need to take my word for it: Sir Jim Mackey, the chief executive of the NHS, said: 'We are using every tool to ensure patients get the best possible treatment. Expanding the use of new tech, such as robotic surgery, will play a huge part.' Wes Streeting, the health and social care secretary, added: 'I know how important this is. The NHS saved my life from kidney cancer with an operation led by a world-class surgeon being helped by a robot.'
Daily Mail
2 hours ago
- Daily Mail
Revealed: The Brits who need Viagra the most - as NHS figures show which areas show biggest demand for erectile dysfunction drug
New NHS figures have revealed which areas have the highest demand for Viagra. Men from Yorkshire are given the most prescriptions for Viagra or similar performance-aiding drugs. The East Riding of Yorkshire topped the table with 3.5 per cent of people needing the little blue pill. Coming in at a close second was Northumberland with 3.3 per cent of men using the pill. And in the coastal area of Dorset, which is popular with retirees, 3.2 per cent of men required the pill. On top of that men in the North used Viagra more often that men in the South last year. Those living in London, Cambridgeshire and Berkshire were far less likely to ask for a prescription. But only 1.5 per cent of men in Leicester were prescribed the drug - making it the area with the lowest rate of users in the UK. Consultant urologist Gordon Muir, of London Bridge Hospital, told the Sun: 'NHS provision of this treatment can vary from region to region, as can the ratio of underlying disease which probably explains some of the differences.' Most men occasionally struggle to get or keep an erection due to stress, tiredness, anxiety or drinking too much alcohol. But up to one in five men in the UK (4.3million) suffer erectile dysfunction - when this keeps happening. It can be caused by high blood pressure or cholesterol, hormone problems or side effects from medication. Medicines containing sildenafil, originally developed to treat angina, are often used to treat the condition. It expands blood vessels and boosts blood flow to the genitals. Viagra was originally cooked up by Covid vaccine manufacturer Pfizer in 1989, with hopes that sildenafil citrate could treat high blood pressure. But clinical trials in Wales a few years later saw men report an unusual side effect —they got more erections while taking the medication. The drug was approved in the US and EU in 1998, branded as Viagra, and became one of the fastest selling drugs of all time. Nearly half of men between the ages of 40 and 70 suffer from erectile dysfunction in the UK - this is around 4.3 million people. But reports suggest the 'little blue pill' is now becoming increasingly popular with younger individuals in their twenties and thirties. A 2020 survey of 5,000 people carried out for Upjohn, the maker of Viagra Connect, the over-the-counter version of the drug, showed that 18 per cent of 18-24-year-old men had erection difficulties. And more recently, the ease of getting the drug without a prescription seems to be fueling its popularity with a younger audience. Non-branded sildenafil can be available from the NHS, to treat erectile dysfunction or pulmonary hypertension.
